The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Source of funding and enrollment disparity in cancer clinical trials.
 
Irbaz Bin Riaz
No Relationships to Disclose
 
Hafsah Ijaz
No Relationships to Disclose
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Mahnoor Islam
No Relationships to Disclose
 
Gaurav Kumar
No Relationships to Disclose
 
Aqsa Mumtaz
No Relationships to Disclose
 
Kaneez Zahra Rubab Khakwani
No Relationships to Disclose
 
Ahsan Ayaz
No Relationships to Disclose
 
Nikita Tripathi
No Relationships to Disclose
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; Janssen Oncology; Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Sophia C. Kamran
Employment - Sanofi (I)
Honoraria - Medscape; Varian Medical Systems
 
Jeremy Lyle Warner
Stock and Other Ownership Interests - HemOnc.org
Consulting or Advisory Role - Flatiron Health; Melax Tech; Roche; Westat
 
Alan Haruo Bryce
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Castle Biosciences; Horizon CME; Myovant Sciences; Myovant Sciences; Pfizer; Research to Practice; Research to Practice; Verity Pharmaceuticals
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology (Inst); Phosplatin Therapeutics (Inst)